Showing 4,281 - 4,300 results of 5,016 for search '"brain tumor"', query time: 0.17s Refine Results
  1. 4281

    Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis. by Cakir, M, Grossman, AB

    Published 2009
    “… BACKGROUND: Pituitary adenomas are common intracranial neoplasms, comprising 10 - 15% of all brain tumors. Data from autopsy studies suggest that pituitary adenomas develop in 17 - 25% of the population. …”
    Journal article
  2. 4282

    Effect of 5-Aminolevulinic Acid and Sodium Fluorescein on the Extent of Resection in High-Grade Gliomas and Brain Metastasis by Lasse Cramer Ahrens, Mathias Green Krabbenhøft, Rasmus Würgler Hansen, Nikola Mikic, Christian Bonde Pedersen, Frantz Rom Poulsen, Anders Rosendal Korshoej

    Published 2022-01-01
    “…Here, we give an update and review the latest literature on fluorescence-guided surgery with 5-ALA and SF for brain tumors with emphasis on fluorescence-guided surgery in HGG and brain metastases. …”
    Get full text
    Article
  3. 4283

    Dose-Dependent Transcriptional Response to Ionizing Radiation Is Orchestrated with DNA Repair within the Nuclear Space by Garima Chaturvedi, Avital Sarusi-Portuguez, Olga Loza, Ariel Shimoni-Sebag, Orly Yoron, Yaacov Richard Lawrence, Leor Zach, Ofir Hakim

    Published 2024-01-01
    “…Radiation therapy is commonly used to treat glioblastoma multiforme (GBM) brain tumors. Ionizing radiation (IR) induces dose-specific variations in transcriptional programs, implicating that they are tightly regulated and critical components in the tumor response and survival. …”
    Get full text
    Article
  4. 4284

    Paradoxical role of high mobility group box 1 in glioma: a suppressor or a promoter? by Richard A. Seidu, Min Wu, Zhaoliang Su, Huaxi Xu

    Published 2017-03-01
    “…Gliomas represent 60% of primary intracranial brain tumors and 80% of all malignant types, with highest morbidity and mortality worldwide. …”
    Get full text
    Article
  5. 4285

    Transcription Factors with Targeting Potential in Gliomas by Angeliki-Ioanna Giannopoulou, Dimitrios S. Kanakoglou, Christina Piperi

    Published 2022-03-01
    “…A variety of TFs have been detected to be aberrantly expressed in brain tumors, being highly implicated in critical pathological aspects and progression of gliomas. …”
    Get full text
    Article
  6. 4286

    Review: therapeutic approaches for circadian modulation of the glioma microenvironment by Ella A. Nettnin, Thien Nguyen, Sophia Arana, Maria Isabel Barros Guinle, Cesar A. Garcia, Erin M. Gibson, Laura M. Prolo, Laura M. Prolo

    Published 2023-12-01
    “…High-grade gliomas are malignant brain tumors that are characteristically hard to treat because of their nature; they grow quickly and invasively through the brain tissue and develop chemoradiation resistance in adults. …”
    Get full text
    Article
  7. 4287

    vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target by Alejandro Manzanares-Guzmán, Pavel H. Lugo-Fabres, Tanya A. Camacho-Villegas

    Published 2024-03-01
    “…Glioblastoma is the most prevalent and fatal form of primary brain tumors. New targeted therapeutic strategies for this type of tumor are imperative given the dire prognosis for glioblastoma patients and the poor results of current multimodal therapy. …”
    Get full text
    Article
  8. 4288

    Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators by Berta Segura-Collar, Sara Hiller-Vallina, Olaya de Dios, Marta Caamaño-Moreno, Lucia Mondejar-Ruescas, Juan M. Sepulveda-Sanchez, Ricardo Gargini

    Published 2023-05-01
    “…Abstract Glial-origin brain tumors, including glioblastomas (GBM), have one of the worst prognoses due to their rapid and fatal progression. …”
    Get full text
    Article
  9. 4289

    Bisphenol A: Unveiling Its Role in Glioma Progression and Tumor Growth by Liang Niu, Juan Jia, Hu Yang, Shangyu Liu, Hongyu Wang, Yunji Yan, Qiao Li, Qiang Dong, He Zhang, Guoming Zhao, Junqiang Dai, Guoqiang Yuan, Yawen Pan

    Published 2024-02-01
    “…Gliomas represent the most common and lethal category of primary brain tumors. Bisphenol A (BPA), a widely recognized endocrine disruptor, has been implicated in the progression of cancer. …”
    Get full text
    Article
  10. 4290
  11. 4291

    Flaviviruses in AntiTumor Therapy by Alina S. Nazarenko, Mikhail F. Vorovitch, Yulia K. Biryukova, Nikolay B. Pestov, Ekaterina A. Orlova, Nickolai A. Barlev, Nadezhda M. Kolyasnikova, Aydar A. Ishmukhametov

    Published 2023-09-01
    “…The key advantages of flaviviruses include their reproduction cycle occurring entirely within the cytoplasm (avoiding genome integration) and their ability to cross the blood–brain barrier, facilitating the systemic delivery of oncolytics against brain tumors. So far, the direct lytic effects and immunomodulatory activities of many flaviviruses have been widely studied in experimental animal models across various types of tumors. …”
    Get full text
    Article
  12. 4292

    A feasible strategy of fabricating camptothecin (SN38)-loaded holmium ferrite nanocarrier delivery for glioma treatment by Yu Zeng, Huihui Chen, Fan Yang, Huiyong Li, Pengxiang Yang

    Published 2022-01-01
    “…Malignant gliomas are the most prevalent and deadly primary brain tumors. The life expectancy of people with gliomas only slightly increases through surgical procedures, radiation, and chemotherapy. …”
    Get full text
    Article
  13. 4293
  14. 4294

    Curcumin, inflammation, and neurological disorders: How are they linked? by Prachi Garodia, Mangala Hegde, Ajaikumar B. Kunnumakkara, Bharat B. Aggarwal

    Published 2023-09-01
    “…The effects of curcumin on neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), brain tumors, epilepsy, Huntington's disorder (HD), ischemia, Parkinson's disease (PD), multiple sclerosis (MS), and traumatic brain injury (TBI) with a major focus on associated signalling pathways have been thoroughly discussed. …”
    Get full text
    Article
  15. 4295

    Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells by Luca X. Zampieri, Martina Sboarina, Andrea Cacace, Debora Grasso, Léopold Thabault, Loïc Hamelin, Thibaut Vazeille, Elodie Dumon, Rodrigue Rossignol, Raphaël Frédérick, Etienne Sonveaux, Florence Lefranc, Pierre Sonveaux

    Published 2021-11-01
    “…Glioblastoma represents the highest grade of brain tumors. Despite maximal resection surgery associated with radiotherapy and concomitant followed by adjuvant chemotherapy with temozolomide (TMZ), patients have a very poor prognosis due to the rapid recurrence and the acquisition of resistance to TMZ. …”
    Get full text
    Article
  16. 4296

    Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma by Jianing Chen, Hainan Yang, Chao Zhao, Tao Lin, Da Liu, Weiping Hong, Changguo Shan, Cheng Zhou, Ling Bao, Caicun Zhou, Linbo Cai, Chunxia Su, Zhaoming Zhou, Lei Wen

    Published 2023-06-01
    “…The difference in their genomic characterization is unclear. 96 lung adenocarcinoma patients were enrolled in our study. 53 patients (55%) had synchronous metastatic brain tumors. 43 (45%) patients had metachronous brain metastases. …”
    Get full text
    Article
  17. 4297

    Schinzel-Giedion syndrome: a rare cause of psychomotor delay and refractory seizures by Gordana Kovačević, Ružica Kravljanac, Biljana Vučetić Tadić, Slavica Ostojić, Seung Woo Ryu

    Published 2024-03-01
    “…Affected children have increased risk of developing neuroepithelial brain tumors.We are reporting a case of a 20 months-old boy with profound psychomotor delay, distinctive facial features, congenital cardiac defect and renal malformation, associated with drug-resistant seizures and progressive brain atrophy. …”
    Get full text
    Article
  18. 4298

    Mapping and Quantification of Non-Coding RNA Originating from the rDNA in Human Glioma Cells by Anastasia A. Sadova, Natalia S. Kupriyanova, Galina V. Pavlova

    Published 2020-07-01
    “…In this study, we demonstrate that the region ~2 kb upstream of the rDNA promoter is transcriptionally active in one type of the most malignant human brain tumors, and we compare its expression rate to that of healthy human tissues and cell cultures. …”
    Get full text
    Article
  19. 4299

    Oculomotor nerve palsy in neurofibromatosis type 2 by Aymen Shahab, MBBS, Hafsa Sardar, MBBS, Samaa Akhtar, MD, MSc, Anam Safdar, MBBS,FCPS, Muhammad Ismail Safi, MD, Izaz Ahmad, Faheemullah Khan, MBBS,MD

    Published 2022-11-01
    “…We describe a 20-year-old patient, with a family history of brain tumors, with symptoms of left sided third nerve palsy. …”
    Get full text
    Article
  20. 4300

    The experience of stereotactic radiosurgery and radiotherapy use in combined treatment of pituitary adenomas by Andrey Gryazov, Olga Chuvashova, Nikolay Guk, Aleksandr Guk, Yuliya Medvedovskaya, Elena Andriychenko, Vitaliy Zakordonets

    Published 2015-05-01
    “…Pituitary tumors take the third place in a structure of CNS neoplasms and ranged from 4 to 17% of all brain tumors.The purpose. To study features of stereotactic ray methods in treatment of pituitary adenomas, to estimate efficacy of stereotactic radiosurgery and stereotactic radiotherapy in pituitary adenomas combined treatment.Materials and methods. …”
    Get full text
    Article